Document is current
Any future updates will be listed below
-
Authors
Thompson, Joe Sneath
Madrid, Laura https://orcid.org/0000-0001-5851-3341
Hernando, Barbara https://orcid.org/0000-0003-4019-2732
Sauer, Carolin M. https://orcid.org/0000-0003-2168-6630
Vias, Maria
Escobar-Rey, Maria
Leung, Wing-Kit
Garcia-Lopez, Diego https://orcid.org/0009-0006-0694-4434
Huckstep, Jamie https://orcid.org/0009-0004-8398-5112
Sekowska, Magdalena
Hosking, Karen
Jimenez-Linan, Mercedes
Reinius, Marika A. V. https://orcid.org/0000-0002-9778-3317
Roy, Abhipsa
Abdulle, Omar
Pangonyte, Justina https://orcid.org/0009-0000-3171-0396
Dobson, Harry https://orcid.org/0009-0001-6994-7011
Cullen, Amy E. https://orcid.org/0000-0002-5015-1355
De Silva, Dilrini https://orcid.org/0000-0003-3963-0141
Gómez-Sánchez, David
Torres, Marina https://orcid.org/0000-0003-0272-9922
Fernández-Sanromán, Ángel
Sanders, Deborah
Martins, Filipe Correia
Funingana, Ionut-Gabriel
Codacci-Pisanelli, Giovanni
Quintela-Fandino, Miguel https://orcid.org/0000-0003-1648-1964
Markowetz, Florian https://orcid.org/0000-0002-2784-5308
Yip, Jason
Brenton, James D. https://orcid.org/0000-0002-5738-6683
Piskorz, Anna M. https://orcid.org/0000-0002-7171-1120
Macintyre, Geoff https://orcid.org/0000-0003-3906-467X
-
Funding
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (CEX2019-000891-S, CEX2019-000891-S, CEX2019-000891-S)
“la Caixa” Foundation (ID 100010434; LCF/BQ/PR23/11980033, LCF/BQ/DI22/11940038, ID 100010434; LCF/BQ/DR21/11880009)
Cancer Research UK (C14303/A17197, A19274, C14303/A17197, C14303/A17197)
Innovate UK
- License Information
-
More Information
Article History
Received: 21 July 2023
Accepted: 16 May 2025
First Online: 23 June 2025
Competing interests
: G.M., A.M.P., J.D.B., J.Y. and F.M. are co-founders, directors and shareholders of Tailor Bio Ltd. J.S.T., L.M., D.G.-L., A.R., O.A. and A.E.C. are current or recent employees and shareholders of Tailor Bio Ltd. M.E.-R., W.-K.L., H.D. and D.D.S. are current or previous employees of Tailor Bio Ltd. G.M., F.M., A.M.P. and J.D.B. are inventors on a patent on using copy number signatures to predict response to doxorubicin treatment in ovarian cancer (patent no. PCT/EP2021/065058). G.M., B.H. and F.M. are inventors on a patent on a method for identifying pan-cancer copy number signatures (patent no. PCT/EP2022/077473). G.M., D.G.-L. and D.G.-S. are inventors on a patent on a method for capture bias correction for copy number calling in targeted sequencing data (patent no. PCT/EP2024/070580). The other authors declare no competing interests.
